Generic drug use in Japan has started to increase but 'brand loyalty' is still a considerable challenge according to industry experts.
Mylan has recalled eight lots of injectables after foreign particulate matter was observed during the testing of samples.
And microbiology awards to research scientists and Médecins Sans Frontières.
Pfizer reduced costs 40% without cutting jobs at a facility in Sweden using an alternative approach to organisational and cultural behaviour, and hopes to do the same at its newly acquired Austrian plant.
Technology transfer is the first step to bringing pharma investments to Africa, says the African Regulatory Network (ARN).
A small molecule combination therapy has shown promise in defeating breast cancers resistant to the usual treatments.